Singapore Institute of Advanced Medicine Holdings Ltd. (SG:9G2) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Singapore Institute of Advanced Medicine Holdings Ltd. is extending its strategic partnership with biotech firm EnGeneIC Pty Limited, following promising developments in EnGeneIC’s proprietary technology, the EnGeneIC Dream Vector. The companies have agreed to a 180-day extension to finalize a Definitive Agreement, with EnGeneIC bound by certain exclusivity obligations during this period. This move signifies a deepening of the collaborative efforts in the manufacturing and distribution of EDV-based products and theranostics.
For further insights into SG:9G2 stock, check out TipRanks’ Stock Analysis page.